Annual Cash & Cash Equivalents
$22.12 M
+$3.95 M+21.77%
December 1, 2023
Summary
- As of February 7, 2025, RCEL annual cash & cash equivalents is $22.12 million, with the most recent change of +$3.95 million (+21.77%) on December 1, 2023.
- During the last 3 years, RCEL annual cash & cash equivalents has fallen by -$88.63 million (-80.03%).
- RCEL annual cash & cash equivalents is now -80.03% below its all-time high of $110.75 million, reached on June 30, 2021.
Performance
RCEL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$18.64 M
+$1.19 M+6.80%
September 1, 2024
Summary
- As of February 7, 2025, RCEL quarterly cash and cash equivalents is $18.64 million, with the most recent change of +$1.19 million (+6.80%) on September 1, 2024.
- Over the past year, RCEL quarterly cash and cash equivalents has dropped by -$3.48 million (-15.73%).
- RCEL quarterly cash and cash equivalents is now -83.78% below its all-time high of $114.88 million, reached on March 31, 2021.
Performance
RCEL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RCEL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.8% | -15.7% |
| 3 y3 years | -80.0% | -69.2% |
| 5 y5 years | +9.6% | -83.8% |
RCEL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.2% | +21.8% | -69.2% | +10.0% |
| 5 y | 5-year | -80.0% | +21.8% | -83.8% | +10.0% |
| alltime | all time | -80.0% | >+9999.0% | -83.8% | >+9999.0% |
AVITA Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.64 M(+6.8%) |
| Jun 2024 | - | $17.45 M(+3.0%) |
| Mar 2024 | - | $16.95 M(-23.4%) |
| Dec 2023 | $22.12 M(+21.8%) | $22.12 M(-56.5%) |
| Sep 2023 | - | $50.85 M(+35.7%) |
| Jun 2023 | - | $37.48 M(+33.6%) |
| Mar 2023 | - | $28.05 M(+54.4%) |
| Dec 2022 | $18.16 M(-67.3%) | $18.16 M(-23.0%) |
| Sep 2022 | - | $23.60 M(-32.1%) |
| Jun 2022 | - | $34.74 M(+47.6%) |
| Mar 2022 | - | $23.54 M(-61.1%) |
| Dec 2021 | $55.51 M(-49.9%) | - |
| Sep 2021 | - | $60.48 M(-45.4%) |
| Jun 2021 | $110.75 M(+50.4%) | $110.75 M(-3.6%) |
| Mar 2021 | - | $114.88 M(+92.2%) |
| Dec 2020 | - | $59.77 M(-9.1%) |
| Sep 2020 | - | $65.75 M(-10.7%) |
| Jun 2020 | $73.64 M(+265.0%) | $73.64 M(-15.6%) |
| Dec 2019 | - | $87.27 M(+332.6%) |
| Jun 2019 | $20.17 M(+85.2%) | $20.17 M(-5.6%) |
| Dec 2018 | - | $21.37 M(+96.3%) |
| Jun 2018 | $10.89 M(+273.9%) | $10.89 M(+18.6%) |
| Dec 2017 | - | $9.19 M(+215.4%) |
| Jun 2017 | $2.91 M(-6.5%) | $2.91 M(-51.8%) |
| Dec 2016 | - | $6.04 M(+93.9%) |
| Jun 2016 | $3.12 M(+1540.6%) | $3.12 M(-44.5%) |
| Dec 2015 | - | $5.62 M(+2858.3%) |
| Jun 2015 | $189.90 K(-94.5%) | $189.90 K(-86.4%) |
| Dec 2014 | - | $1.40 M(-59.4%) |
| Jun 2014 | $3.43 M(-64.5%) | $3.43 M(-43.0%) |
| Dec 2013 | - | $6.03 M(-37.8%) |
| Jun 2013 | $9.69 M(+15.0%) | $9.69 M(-34.7%) |
| Dec 2012 | - | $14.84 M(+76.2%) |
| Jun 2012 | $8.42 M | $8.42 M(-23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $11.07 M(-18.2%) |
| Jun 2011 | $13.54 M(+312.1%) | $13.54 M(+362.8%) |
| Dec 2010 | - | $2.93 M(-11.0%) |
| Jun 2010 | $3.29 M(+17.1%) | $3.29 M(-12.9%) |
| Dec 2009 | - | $3.77 M(+34.5%) |
| Jun 2009 | $2.81 M(-65.3%) | $2.81 M(-28.1%) |
| Dec 2008 | - | $3.90 M(-51.8%) |
| Jun 2008 | $8.10 M(-22.4%) | $8.10 M(-13.5%) |
| Dec 2007 | - | $9.36 M(-10.3%) |
| Jun 2007 | $10.44 M(+64.0%) | $10.44 M(-17.8%) |
| Dec 2006 | - | $12.70 M(+99.6%) |
| Jun 2006 | $6.37 M(+150.7%) | $6.37 M(-36.0%) |
| Dec 2005 | - | $9.95 M(-0.6%) |
| Dec 2004 | - | $10.01 M(+294.2%) |
| Jun 2004 | $2.54 M(+14.8%) | $2.54 M(-52.2%) |
| Dec 2003 | - | $5.32 M(+162.7%) |
| Jun 2003 | - | $2.02 M(-8.5%) |
| Dec 2002 | $2.21 M(-33.5%) | $2.21 M(-36.5%) |
| Jun 2002 | - | $3.48 M(+4.7%) |
| Dec 2001 | $3.33 M(+1.9%) | - |
| Dec 2001 | - | $3.33 M(+44.8%) |
| Jun 2001 | - | $2.30 M(-29.6%) |
| Dec 2000 | $3.26 M(+57.9%) | - |
| Dec 2000 | - | $3.26 M(-18.6%) |
| Jun 2000 | - | $4.01 M(+94.0%) |
| Dec 1999 | $2.07 M(+6379.3%) | - |
| Dec 1999 | - | $2.07 M(+6379.3%) |
| Dec 1998 | $31.90 K(-63.0%) | - |
| Dec 1998 | - | $31.90 K(-63.0%) |
| Dec 1997 | $86.30 K(+1736.2%) | - |
| Dec 1997 | - | $86.30 K |
| Dec 1996 | $4700.00(-69.9%) | - |
| Dec 1995 | $15.60 K(-61.3%) | - |
| Dec 1994 | $40.30 K(-82.3%) | - |
| Dec 1993 | $227.60 K | - |
FAQ
- What is AVITA Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AVITA Medical?
- What is AVITA Medical annual cash & cash equivalents year-on-year change?
- What is AVITA Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AVITA Medical?
- What is AVITA Medical quarterly cash and cash equivalents year-on-year change?
What is AVITA Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of RCEL is $22.12 M
What is the all time high annual cash & cash equivalents for AVITA Medical?
AVITA Medical all-time high annual cash & cash equivalents is $110.75 M
What is AVITA Medical annual cash & cash equivalents year-on-year change?
Over the past year, RCEL annual cash & cash equivalents has changed by +$3.95 M (+21.77%)
What is AVITA Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RCEL is $18.64 M
What is the all time high quarterly cash and cash equivalents for AVITA Medical?
AVITA Medical all-time high quarterly cash and cash equivalents is $114.88 M
What is AVITA Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, RCEL quarterly cash and cash equivalents has changed by -$3.48 M (-15.73%)